Bionano Genomics, Inc. (BNGO) Form S-1 — Oct 27, 2026
Bionano Genomics filed a new S-1 to register 1,332,632 shares of common stock issuable upon exercise of outstanding warrants issued between October 2023 and January 2025, after its prior S-3 shelf (No. 333-270459) expires on November 6, 2026. The filing is purely administrative — no underwriters, no new offering, and the company receives proceeds only if warrant holders exercise. The warrants are deeply out of the money: exercise prices range from $15.12 to $191.13 versus a BNGO share price of $1.16 on October 26, 2026.
Key figures
- Shares Offered
- 1332632
- Shares Outstanding
- 13976957
- 52wk low
- 1.06
- 52wk high
- 1.87
- Stock price oct 26 2026
- 1.16
- Warrant exercise prices
- [15.12,18.234,61.2,191.13]
- Post offering shares outstanding
- 15309589
- Potential warrant exercise proceeds
- approximately $90 million
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.